Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Teva Reports Second Quarter 2009 Results
Teva Pharmaceutical Industries, 07/29/09
Net sales for the quarter increased 20% to $3,400 million, compared to $2,823 million in the second quarter of 2008. The acquisition of Barr contributed to the growth in sales in all of Teva's geographies, particularly in the U.S., Russia, Poland, Germany, and Croatia.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Declares 344th Consecutive Quarterly Dividend
Abbott, 12/15/09
Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering
Dendreon Coproration, 12/15/09
Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09
Article Search
Sponsor